Closing the Innovation Gap in Drug Development in Japan Through Academia and Industry Collaboration

From Raw Data to Real Time Insight: Visualizing Study Data for Smarter Study Decisions

Mitigating study start-up risks in a biotech's early phase immuno-oncology study

Tyler Knight, MS

Tyler Knight, MS, is a Senior Director and real-world evidence (RWE) data scientist who co-leads the RWE & Analytics service within Fortrea’s Market Access Consulting and HEOR group.

Alison Howell, PhD

Alison Howell, PhD, is a Senior Director who leads the Value Demonstration service within Fortrea’s Market Access Consulting and HEOR group. She has over 18 years of experience in market access consulting.

Sam Colman, MSc

Sam Colman, MSc, is a Senior Director and real-world evidence (RWE) biostatistician who co-leads the RWE & Analytics service within Fortrea’s Market Access Consulting and HEOR group.

John Carlsen, MHA

John Carlsen, MHA, is a Vice President who leads the Reimbursement Strategy & Payer Insights service within Fortrea’s Market Access Consulting and HEOR group.

Kristi Baum-Skorija, MBA

Kristi Baum-Skorija, MBA, is an Executive Director who leads reimbursement strategy projects within Fortrea’s Market Access Consulting and HEOR group.

Barbara Mascialino, PhD

Barbara Mascialino is a Senior Director who leads the Health Economic Modeling & HTA service within Fortrea’s Market Access Consulting and HEOR Consulting group.

Gordon Cummins, MS

Gordon Cummins, MS, is an Executive Director who leads our Integrated Evidence Platform service area in Fortrea’s Market Access Consulting and HEOR group.